Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of BI-1206 in Combination With Rituximab in Subjects With Indolent B-Cell Non-Hodgkin Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03571568
Recruitment Status : Recruiting
First Posted : June 27, 2018
Last Update Posted : April 1, 2019
Sponsor:
Information provided by (Responsible Party):
BioInvent International AB

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : June 30, 2020
  Estimated Study Completion Date : June 30, 2020